These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 987558
1. Vaginal adenosis. Factors influencing detection in a colposcopic evaluation. Burke L, Antonioli D. Obstet Gynecol; 1976 Oct; 48(4):413-21. PubMed ID: 987558 [Abstract] [Full Text] [Related]
10. Clinical detection of vaginal adenosis and clear-cell adenocarcinoma. Stafl A. J Reprod Med; 1975 Jul 01; 15(1):19-24. PubMed ID: 1167309 [No Abstract] [Full Text] [Related]
11. Squamous cell carcinoma in situ of the vagina and cervix after intrauterine DES exposure. Veridiano NP, Tancer ML, Weiner EA. Obstet Gynecol; 1978 Jul 01; 52(1 Suppl):30S-33S. PubMed ID: 683639 [Abstract] [Full Text] [Related]
12. The management of DES-exposed women: one physician's approach. Scott JW. J Reprod Med; 1976 Jun 01; 16(6):285-8. PubMed ID: 957347 [Abstract] [Full Text] [Related]
13. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals. Clin Pediatr (Phila); 1983 Feb 01; 22(2):139-43. PubMed ID: 6822019 [Abstract] [Full Text] [Related]
17. Value of screening procedures for the detection of vaginal adenosis. Gunning JE, Ostegard DR. Obstet Gynecol; 1976 Mar 01; 47(3):268-71. PubMed ID: 55991 [Abstract] [Full Text] [Related]
18. In utero exposure to DES. Evaluation and followup of 199 women. Fowler WC, Edelman DA. Obstet Gynecol; 1978 Apr 01; 51(4):459-63. PubMed ID: 662229 [Abstract] [Full Text] [Related]
19. Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol. Scully RE, Robboy SJ, Herbst AL. Ann Clin Lab Sci; 1974 Apr 01; 4(4):222-33. PubMed ID: 4460850 [Abstract] [Full Text] [Related]